Skip to content

Clinical Efficacy and Network Remodeling of Cognitive-Motor Dual-Task Training in Post-Stroke Cognitive Impairment

Clinical Efficacy and Network Remodeling of Cognitive-Motor Dual-Task Training in Post-Stroke Cognitive Impairment

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118293
Enrollment
Unknown
Registered
2026-02-04
Start date
2026-02-06
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke Cognitive Impairment,PSCI

Interventions

Cognitive-Motor Dual-Task Training:Patients undergo training combining cognitive tasks with synchronized upper limb motor function intervention. Cognitive tasks are personalized based on initial cogni
Motor training:Standardized exercise rehabilitation including functional upper limb tasks (such as reaching, grasping, and fine manipulation). Training intensity is gradually increased based on patien
Cognitive Training:Patients underwent cognitive training using a computer-assisted cognitive rehabilitation system. The training content was identical to that of the CMDT group, with tasks individuall

Sponsors

Shiyan Taihe Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 30 years old <= age <= 75 years old, with primary school education or above; 2. The diagnosis of the first stroke is in accordance with the diagnostic points of post-stroke cognitive impairment adopted by the 2021 Expert Consensus on the Management of Post-Stroke Cognitive Impairment; 3. The duration of the disease is from 3 months to 6 months after the stroke, and the vital signs are stable; 4. the presence of upper limb motor dysfunction, with a Fugl-meyer assessment of Upper Extremity (FMA-UE) score between 23 and 55; 5. able to follow experimental instructions; 6. the patient is right-handed and able to remain seated for more than 30 minutes; 7. The patient himself/herself signed or his/her immediate family members signed the informed consent form on his/her behalf.

Exclusion criteria

Exclusion criteria: 1. have a history of severe cognitive impairment or dementia (Mini Mental State Examination, MMSE <18) or previous illnesses other than PSCI that cause cognitive dysfunction; 2. have severe visual, hearing, or speech impairments that prevent them from understanding and cooperating with instructions; 3. Presence of uncontrolled psychiatric mental illness that interferes with cooperation with interventions; 4. Combination of severe motor dysfunction, affecting intervention and assessment; 5. the presence of a comorbid serious cardiac, hepatic, renal or respiratory disorder that does not tolerate rehabilitation; 6. Inappropriate for fNIRS collection due to trauma to the scalp or skull; 7. concurrent participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;

Secondary

MeasureTime frame
Fugl-meyer assessment of Upper Extremity,FMA-UE;Trail Making Test A/B;Brain oxygen saturation;Modified Barthel Index;Event-related potentialP300;

Countries

China

Contacts

Public ContactMingfen Li

Shiyan Taihe Hospital

376375763@qq.com+86 158 9786 4957

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026